Semaglutide survey: Exclusive physician results on benefits, challenges of new obesity drugs

If it feels like the new antiobesity medicines are everywhere, you may not be far off.

More than three-quarters of family medicine and internal medicine physicians said they have prescribed the drugs, according to survey, “Physician Use and Perceptions of GLP-1 Drugs for Weight Loss.” That online poll was posted this fall by Medical Economics and sister publication Patient Care.

The survey asked physicians about their experiences, and those of their patients, using the new Glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs).

So, are the drugs all hype or truly helpful? What about side effects? Is cost a factor in physician and patient decision-making?

Here are the results.